Empresa Gracell Biotechnologies Inc.
Acciones
GRCL
US38406L1035
Biotecnología e investigación médica
Resumen de negocios
Número de empleados: 314
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Wei Cao
CEO | Chief Executive Officer | 66 | 01/05/17 |
Yi Li Xie
DFI | Director of Finance/CFO | 54 | 24/07/20 |
Wendy Li
CTO | Chief Tech/Sci/R&D Officer | 66 | 01/08/22 |
Gracie Tong
IRC | Investor Relations Contact | - | - |
Samuel Zhang
PRN | Corporate Officer/Principal | - | 19/07/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Wei Cao
CEO | Chief Executive Officer | 66 | 01/05/17 |
Guo Tong Xu
BRD | Director/Board Member | 67 | 01/02/19 |
Guo Wei Wang
BRD | Director/Board Member | 63 | 01/03/20 |
Kin Ping Lee
BRD | Director/Board Member | 56 | 09/07/21 |
Wendy Hayes
BRD | Director/Board Member | 54 | 07/01/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 61 364 562 | 0 | 0 | 83,58 % |
Acción B | 0 | 59 327 653 | 0 | 0 | |
Acción C | 1 | 479 632 139 | 400 876 542 ( 83,58 %) | 0 | |
Acción D | 0 | 21 735 721 | 0 | 0 | |
Acción E | 0 | 31 343 284 | 0 | 0 |
Información de la empresa
Gracell Biotechnologies, Inc.
Biobay & Suzhou Industrial Park 218 Sangtian Street
215123, Suzhou
+
http://www.gracellbio.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+4,09 % | 43,84 mil M | |
+47,07 % | 41,25 mil M | |
+9,45 % | 41,68 mil M | |
-10,92 % | 27,04 mil M | |
+9,32 % | 25,53 mil M | |
-24,87 % | 18,18 mil M | |
+29,70 % | 12,29 mil M | |
+1,28 % | 12,29 mil M | |
+7,78 % | 11,15 mil M |